News Dan McKernan 5/1/25 Dan McKernan 5/1/25 FDA approval of Abeona Therapeutics' ZEVASKYN accelerates momentum and expands treatment options for the EB community. Read More Research Dan McKernan 3/26/25 Research Dan McKernan 3/26/25 EMA Recommends Approval of Vyjuvek Read More
Dan McKernan 5/1/25 Dan McKernan 5/1/25 FDA approval of Abeona Therapeutics' ZEVASKYN accelerates momentum and expands treatment options for the EB community. Read More
Research Dan McKernan 3/26/25 Research Dan McKernan 3/26/25 EMA Recommends Approval of Vyjuvek Read More
